Close Menu

NEW YORK — Roche Diagnostics recently took over development of a proof-of-principle prototype that could become a model for future point-of-care platforms, according to Christian Tidona, founder and managing director of Heidelberg, Germany-based BioMed X.

Specifically, Roche has taken on development of a multimodal diagnostic platform invented and developed by scientists at the BioMed X Innovation Center in Heidelberg. If Roche is successful, the platform could enable testing for several conditions in one setting and provide an alternative to laboratory tests, Tidona added.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.